Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantation

Author: Lohmann R.   Langrehr J.M.   Klupp J.   Neumann U.   Guckelberger O.   Muller A.R.   Nussler N.C.   Jonas S.   Lang M.   Settmacher U.   Bechstein W.-O.   Neuhaus P.J.  

Publisher: Elsevier

ISSN: 0041-1345

Source: Transplantation Proceedings, Vol.31, Iss.1, 1999-02, pp. : 380-380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content